DTL
INSY

Dynamic Technology Lab’s Insys Therapeutics, Inc. INSY Stock Holding History

Dynamic Technology Lab’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-13,403
Closed -$119K – 1509
2017
Q3 		$119K Buy
+13,403
New +$138K 0.02% 963
2017
Q1 		– Sell
-10,095
Closed -$93K – 1409
2016
Q4 		$93K Buy
+10,095
New +$114K 0.03% 817

Other funds holding INSY

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dynamic Technology Lab's INSY Position: Q4 2017 in Review

Dynamic Technology Lab sold out of Insys Therapeutics, Inc. (INSY) in Q4 2017, closing a stake of 13,403 shares — an estimated $119K sold.

Dynamic Technology Lab first reported a position in INSY in Q4 2016 and held it in 2 quarters. The position peaked at $119K in Q3 2017. 112 funds tracked by Wall St. Rank hold INSY as of Q4 2017.

  • Dynamic Technology Lab reported no remaining Insys Therapeutics, Inc. position as of Q4 2017 after selling out during the quarter.
  • Dynamic Technology Lab sold 13,403 Insys Therapeutics, Inc. shares in Q4 2017, an estimated $119K.
  • Dynamic Technology Lab first reported a position in Insys Therapeutics, Inc. in Q4 2016 and held it in 2 quarters.
  • Dynamic Technology Lab's Insys Therapeutics, Inc. position peaked at $119K in Q3 2017.
  • 112 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q4 2017.

Based on Dynamic Technology Lab's 13F filing for Q4 2017, filed 9 Feb 2018.